| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium channel inhibitor activity | 6.08e-05 | 8 | 30 | 2 | GO:0019871 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.29e-04 | 18 | 30 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 5.90e-04 | 24 | 30 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.27e-04 | 118 | 30 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.05e-04 | 28 | 30 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.41e-03 | 37 | 30 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | sodium channel regulator activity | 1.98e-03 | 44 | 30 | 2 | GO:0017080 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.11e-03 | 171 | 30 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 2.36e-03 | 48 | 30 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 2.46e-03 | 49 | 30 | 2 | GO:0048487 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 2.56e-03 | 50 | 30 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 2.66e-03 | 51 | 30 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 2.76e-03 | 52 | 30 | 2 | GO:0043014 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.69e-03 | 227 | 30 | 3 | GO:0051015 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.92e-03 | 465 | 30 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.95e-03 | 70 | 30 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.04e-03 | 758 | 30 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 5.21e-03 | 1099 | 30 | 6 | GO:0008092 | |
| GeneOntologyMolecularFunction | actin binding | 5.47e-03 | 479 | 30 | 4 | GO:0003779 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.75e-07 | 208 | 30 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.41e-06 | 275 | 30 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 7.53e-05 | 1017 | 30 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transporter activity | 7.70e-05 | 57 | 30 | 3 | GO:2000649 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at postsynapse | 9.14e-05 | 10 | 30 | 2 | GO:0140252 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transport | 1.36e-04 | 69 | 30 | 3 | GO:1902305 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at synapse | 1.84e-04 | 14 | 30 | 2 | GO:0140250 | |
| GeneOntologyBiologicalProcess | phosphate ion transmembrane transport | 2.12e-04 | 15 | 30 | 2 | GO:0035435 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transmembrane transporter activity | 2.42e-04 | 16 | 30 | 2 | GO:2000650 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transmembrane transport | 2.74e-04 | 17 | 30 | 2 | GO:1902306 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 2.88e-04 | 922 | 30 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 3.28e-04 | 942 | 30 | 7 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 4.20e-04 | 101 | 30 | 3 | GO:0002028 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 4.35e-04 | 449 | 30 | 5 | GO:0002449 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 4.45e-04 | 103 | 30 | 3 | GO:0048814 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transport | 4.64e-04 | 22 | 30 | 2 | GO:0010766 | |
| GeneOntologyBiologicalProcess | metal ion transport | 4.70e-04 | 1000 | 30 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 5.25e-04 | 109 | 30 | 3 | GO:0035082 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 6.59e-04 | 1058 | 30 | 7 | GO:0007017 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 6.65e-04 | 493 | 30 | 5 | GO:0007018 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 9.00e-04 | 1115 | 30 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 9.26e-04 | 31 | 30 | 2 | GO:0006817 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 1.12e-03 | 1157 | 30 | 7 | GO:0006812 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.20e-03 | 145 | 30 | 3 | GO:0001578 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.33e-03 | 150 | 30 | 3 | GO:0050773 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 1.33e-03 | 576 | 30 | 5 | GO:0002443 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 1.43e-03 | 154 | 30 | 3 | GO:0007368 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 1.47e-03 | 39 | 30 | 2 | GO:0099149 | |
| GeneOntologyCellularComponent | dynein complex | 6.30e-05 | 54 | 30 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 8.11e-05 | 317 | 30 | 5 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.47e-04 | 360 | 30 | 5 | GO:0099568 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.85e-04 | 25 | 30 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | spindle midzone | 1.50e-03 | 40 | 30 | 2 | GO:0051233 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.56e-03 | 161 | 30 | 3 | GO:0005875 | |
| MousePheno | left pulmonary isomerism | 1.48e-05 | 31 | 22 | 3 | MP:0003178 | |
| MousePheno | dual inferior vena cava | 1.96e-05 | 34 | 22 | 3 | MP:0011683 | |
| MousePheno | left-sided isomerism | 1.96e-05 | 34 | 22 | 3 | MP:0000542 | |
| MousePheno | situs inversus with levocardia | 4.94e-05 | 7 | 22 | 2 | MP:0011253 | |
| MousePheno | abnormal right lung morphology | 5.25e-05 | 47 | 22 | 3 | MP:0009570 | |
| MousePheno | transposition of great arteries | 5.25e-05 | 47 | 22 | 3 | MP:0004110 | |
| MousePheno | left atrial isomerism | 6.58e-05 | 8 | 22 | 2 | MP:0008461 | |
| MousePheno | abdominal situs inversus | 8.46e-05 | 9 | 22 | 2 | MP:0011249 | |
| MousePheno | abnormal lung position or orientation | 9.37e-05 | 57 | 22 | 3 | MP:0010853 | |
| MousePheno | schistocytosis | 1.06e-04 | 10 | 22 | 2 | MP:0000314 | |
| MousePheno | pulmonary artery hypoplasia | 1.29e-04 | 11 | 22 | 2 | MP:0010460 | |
| MousePheno | abnormal inferior vena cava morphology | 1.59e-04 | 68 | 22 | 3 | MP:0006063 | |
| MousePheno | abnormal a-wave shape | 1.73e-04 | 70 | 22 | 3 | MP:0012034 | |
| MousePheno | right atrial isomerism | 1.82e-04 | 13 | 22 | 2 | MP:0006061 | |
| MousePheno | spherocytosis | 1.82e-04 | 13 | 22 | 2 | MP:0002812 | |
| MousePheno | abnormal heart position or orientation | 2.04e-04 | 74 | 22 | 3 | MP:0006065 | |
| MousePheno | abnormal sperm flagellum thickness | 2.13e-04 | 14 | 22 | 2 | MP:0031351 | |
| MousePheno | abnormal vena cava morphology | 2.29e-04 | 77 | 22 | 3 | MP:0006062 | |
| MousePheno | abnormal retina cone cell morphology | 2.29e-04 | 77 | 22 | 3 | MP:0001006 | |
| MousePheno | abnormal retina rod cell morphology | 2.38e-04 | 78 | 22 | 3 | MP:0001005 | |
| MousePheno | abdominal situs ambiguus | 2.80e-04 | 16 | 22 | 2 | MP:0011250 | |
| MousePheno | abnormal heart atrium arrangement | 3.17e-04 | 17 | 22 | 2 | MP:0014319 | |
| MousePheno | abnormal retina cone cell outer segment morphology | 3.56e-04 | 18 | 22 | 2 | MP:0008449 | |
| MousePheno | heterotaxia | 3.64e-04 | 90 | 22 | 3 | MP:0004133 | |
| MousePheno | pale liver | 3.88e-04 | 92 | 22 | 3 | MP:0000603 | |
| MousePheno | duplex kidney | 3.98e-04 | 19 | 22 | 2 | MP:0004017 | |
| MousePheno | abnormal heart atrium morphology | 4.27e-04 | 232 | 22 | 4 | MP:0003105 | |
| MousePheno | mesocardia | 4.42e-04 | 20 | 22 | 2 | MP:0000650 | |
| MousePheno | abdominal situs abnormality | 4.88e-04 | 21 | 22 | 2 | MP:0031284 | |
| MousePheno | increased growth hormone level | 5.86e-04 | 23 | 22 | 2 | MP:0005137 | |
| MousePheno | situs inversus totalis | 5.86e-04 | 23 | 22 | 2 | MP:0011252 | |
| MousePheno | abnormal electroretinogram waveform feature | 5.88e-04 | 106 | 22 | 3 | MP:0012029 | |
| MousePheno | hydronephrosis | 6.38e-04 | 109 | 22 | 3 | MP:0000519 | |
| MousePheno | decreased leukocyte cell number | 6.60e-04 | 1342 | 22 | 8 | MP:0000221 | |
| MousePheno | retina photoreceptor degeneration | 6.72e-04 | 111 | 22 | 3 | MP:0008450 | |
| MousePheno | abnormal aortic arch morphology | 8.23e-04 | 119 | 22 | 3 | MP:0004113 | |
| MousePheno | abnormal kidney pelvis morphology | 9.27e-04 | 124 | 22 | 3 | MP:0004194 | |
| MousePheno | abnormal respiratory motile cilium physiology | 9.36e-04 | 29 | 22 | 2 | MP:0011055 | |
| MousePheno | blindness | 1.00e-03 | 30 | 22 | 2 | MP:0002001 | |
| MousePheno | right-sided isomerism | 1.00e-03 | 30 | 22 | 2 | MP:0000508 | |
| MousePheno | retina rod cell degeneration | 1.07e-03 | 31 | 22 | 2 | MP:0008451 | |
| MousePheno | right-sided stomach | 1.07e-03 | 31 | 22 | 2 | MP:0010808 | |
| MousePheno | poikilocytosis | 1.07e-03 | 31 | 22 | 2 | MP:0002643 | |
| MousePheno | abnormal thoracic aorta morphology | 1.16e-03 | 134 | 22 | 3 | MP:0010468 | |
| MousePheno | decreased immunoglobulin level | 1.34e-03 | 315 | 22 | 4 | MP:0002460 | |
| MousePheno | abnormal photoreceptor outer segment morphology | 1.34e-03 | 141 | 22 | 3 | MP:0003729 | |
| MousePheno | vascular ring | 1.36e-03 | 35 | 22 | 2 | MP:0010466 | |
| MousePheno | abnormal stomach position or orientation | 1.44e-03 | 36 | 22 | 2 | MP:0010807 | |
| MousePheno | hemolytic anemia | 1.44e-03 | 36 | 22 | 2 | MP:0001585 | |
| MousePheno | abnormal liver size | 1.54e-03 | 562 | 22 | 5 | MP:0004848 | |
| MousePheno | interrupted aortic arch | 1.87e-03 | 41 | 22 | 2 | MP:0004157 | |
| MousePheno | interrupted aorta | 2.05e-03 | 43 | 22 | 2 | MP:0010544 | |
| MousePheno | increased variability of skeletal muscle fiber size | 2.05e-03 | 43 | 22 | 2 | MP:0009403 | |
| Domain | WW | 4.68e-05 | 47 | 28 | 3 | PF00397 | |
| Domain | WW | 4.99e-05 | 48 | 28 | 3 | SM00456 | |
| Domain | WW_DOMAIN_2 | 5.99e-05 | 51 | 28 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 5.99e-05 | 51 | 28 | 3 | PS01159 | |
| Domain | Dynein_heavy_dom-1 | 6.03e-05 | 8 | 28 | 2 | IPR013594 | |
| Domain | DHC_N1 | 6.03e-05 | 8 | 28 | 2 | PF08385 | |
| Domain | WW_dom | 6.35e-05 | 52 | 28 | 3 | IPR001202 | |
| Domain | CH | 1.24e-04 | 65 | 28 | 3 | SM00033 | |
| Domain | CH | 1.54e-04 | 70 | 28 | 3 | PF00307 | |
| Domain | - | 1.61e-04 | 71 | 28 | 3 | 1.10.418.10 | |
| Domain | CH | 1.75e-04 | 73 | 28 | 3 | PS50021 | |
| Domain | CH-domain | 1.90e-04 | 75 | 28 | 3 | IPR001715 | |
| Domain | ATPase_dyneun-rel_AAA | 1.95e-04 | 14 | 28 | 2 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.95e-04 | 14 | 28 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.95e-04 | 14 | 28 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.95e-04 | 14 | 28 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.95e-04 | 14 | 28 | 2 | PF08393 | |
| Domain | MT | 1.95e-04 | 14 | 28 | 2 | PF12777 | |
| Domain | AAA_8 | 1.95e-04 | 14 | 28 | 2 | PF12780 | |
| Domain | AAA_5 | 1.95e-04 | 14 | 28 | 2 | PF07728 | |
| Domain | DHC_fam | 2.25e-04 | 15 | 28 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.25e-04 | 15 | 28 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.25e-04 | 15 | 28 | 2 | PF03028 | |
| Domain | Actinin_actin-bd_CS | 5.38e-04 | 23 | 28 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 5.38e-04 | 23 | 28 | 2 | PS00020 | |
| Domain | ACTININ_1 | 5.38e-04 | 23 | 28 | 2 | PS00019 | |
| Domain | Spectrin | 5.38e-04 | 23 | 28 | 2 | PF00435 | |
| Domain | HECT | 7.43e-04 | 27 | 28 | 2 | PF00632 | |
| Domain | HECTc | 7.43e-04 | 27 | 28 | 2 | SM00119 | |
| Domain | HECT_dom | 7.43e-04 | 27 | 28 | 2 | IPR000569 | |
| Domain | HECT | 7.43e-04 | 27 | 28 | 2 | PS50237 | |
| Domain | ARF | 8.58e-04 | 29 | 28 | 2 | PS51417 | |
| Domain | Small_GTPase_ARF | 8.58e-04 | 29 | 28 | 2 | IPR024156 | |
| Domain | Spectrin_repeat | 8.58e-04 | 29 | 28 | 2 | IPR002017 | |
| Domain | Arf | 9.81e-04 | 31 | 28 | 2 | PF00025 | |
| Domain | Spectrin/alpha-actinin | 1.05e-03 | 32 | 28 | 2 | IPR018159 | |
| Domain | SPEC | 1.05e-03 | 32 | 28 | 2 | SM00150 | |
| Domain | Small_GTPase_ARF/SAR | 1.11e-03 | 33 | 28 | 2 | IPR006689 | |
| Domain | P-loop_NTPase | 7.85e-03 | 848 | 28 | 5 | IPR027417 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14871887 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11502596 | ||
| Pubmed | An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility. | 7.19e-07 | 2 | 30 | 2 | 16537643 | |
| Pubmed | Presynaptic Biogenesis Requires Axonal Transport of Lysosome-Related Vesicles. | 7.19e-07 | 2 | 30 | 2 | 30174114 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23262292 | ||
| Pubmed | Physiological Functions of the Ubiquitin Ligases Nedd4-1 and Nedd4-2. | 7.19e-07 | 2 | 30 | 2 | 37962894 | |
| Pubmed | Down-regulating destruction: phosphorylation regulates the E3 ubiquitin ligase Nedd4-2. | 7.19e-07 | 2 | 30 | 2 | 19602703 | |
| Pubmed | A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+ channel. | 7.19e-07 | 2 | 30 | 2 | 11149908 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12693957 | ||
| Pubmed | Dietary sodium modulates nephropathy in Nedd4-2-deficient mice. | 7.19e-07 | 2 | 30 | 2 | 31802037 | |
| Pubmed | Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein. | 2.16e-06 | 3 | 30 | 2 | 11779188 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18498246 | ||
| Pubmed | Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. | 2.16e-06 | 3 | 30 | 2 | 21852580 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10867799 | ||
| Pubmed | The high-affinity choline transporter CHT1 is regulated by the ubiquitin ligase Nedd4-2. | 2.16e-06 | 3 | 30 | 2 | 22361880 | |
| Pubmed | Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. | 2.16e-06 | 3 | 30 | 2 | 15217910 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 12729930 | ||
| Pubmed | Nedd4-2-mediated ubiquitination facilitates processing of surfactant protein-C. | 2.16e-06 | 3 | 30 | 2 | 19423771 | |
| Pubmed | Regulation of the epithelial sodium channel by N4WBP5A, a novel Nedd4/Nedd4-2-interacting protein. | 2.16e-06 | 3 | 30 | 2 | 12050153 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20730100 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26823285 | ||
| Pubmed | Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy. | 2.16e-06 | 3 | 30 | 2 | 23686771 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15677482 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 27466427 | ||
| Pubmed | SGK1/Nedd4-2 signaling pathway regulates the activity of human organic anion transporters 3. | 4.31e-06 | 4 | 30 | 2 | 28608480 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 17544362 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 15331635 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 20026598 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 31357244 | ||
| Pubmed | Kir5.1 regulates Nedd4-2-mediated ubiquitination of Kir4.1 in distal nephron. | 4.31e-06 | 4 | 30 | 2 | 29897283 | |
| Pubmed | NEDD4-2 associates with gamma(c) and regulates its degradation rate. | 4.31e-06 | 4 | 30 | 2 | 19615332 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22024150 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 11696533 | ||
| Pubmed | Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1. | 4.31e-06 | 4 | 30 | 2 | 21463633 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 6.77e-06 | 313 | 30 | 5 | 38270169 | |
| Pubmed | Molecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins. | 7.18e-06 | 5 | 30 | 2 | 15548568 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 25157163 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 30287686 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 18687683 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 27793840 | ||
| Pubmed | The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation. | 7.18e-06 | 5 | 30 | 2 | 22385262 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 21478478 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 31867777 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 36002265 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 19143627 | ||
| Pubmed | Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. | 7.18e-06 | 5 | 30 | 2 | 19706893 | |
| Pubmed | Rescue of DeltaF508-CFTR by the SGK1/Nedd4-2 signaling pathway. | 7.18e-06 | 5 | 30 | 2 | 19617352 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 25631046 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 18577513 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 17289006 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 15252135 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 37156795 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 27445338 | ||
| Pubmed | Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination. | 1.08e-05 | 6 | 30 | 2 | 16701206 | |
| Pubmed | Regulation of Itch and Nedd4 E3 Ligase Activity and Degradation by LRAD3. | 1.08e-05 | 6 | 30 | 2 | 26854353 | |
| Pubmed | β-Sheet Augmentation Is a Conserved Mechanism of Priming HECT E3 Ligases for Ubiquitin Ligation. | 1.08e-05 | 6 | 30 | 2 | 29964046 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 11748237 | ||
| Pubmed | Stat5 expression is critical for mast cell development and survival. | 1.08e-05 | 6 | 30 | 2 | 12714518 | |
| Pubmed | 1.47e-05 | 55 | 30 | 3 | 31985874 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 30587574 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 11046148 | ||
| Pubmed | Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. | 1.51e-05 | 7 | 30 | 2 | 23644597 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 20051513 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 20086093 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 12176734 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 31178125 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 24831002 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 16337426 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 9256245 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 2.00e-05 | 392 | 30 | 5 | 33144569 | |
| Pubmed | The Nedd4-like protein KIAA0439 is a potential regulator of the epithelial sodium channel. | 2.01e-05 | 8 | 30 | 2 | 11244092 | |
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 24036464 | ||
| Pubmed | Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. | 2.01e-05 | 8 | 30 | 2 | 17719543 | |
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 18981174 | ||
| Pubmed | Expression of Phosphate Transporters during Dental Mineralization. | 2.58e-05 | 9 | 30 | 2 | 28892649 | |
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 15496141 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 14627610 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 25092867 | ||
| Pubmed | 3.94e-05 | 11 | 30 | 2 | 22773947 | ||
| Pubmed | Respiratory distress and perinatal lethality in Nedd4-2-deficient mice. | 3.94e-05 | 11 | 30 | 2 | 21505443 | |
| Pubmed | Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein. | 3.94e-05 | 11 | 30 | 2 | 25963657 | |
| Pubmed | 5.58e-05 | 13 | 30 | 2 | 15123669 | ||
| Pubmed | The Rab7 effector PLEKHM1 binds Arl8b to promote cargo traffic to lysosomes. | 5.58e-05 | 13 | 30 | 2 | 28325809 | |
| Pubmed | BORC, a multisubunit complex that regulates lysosome positioning. | 5.58e-05 | 13 | 30 | 2 | 25898167 | |
| Pubmed | Phosphatidylinositol 4-kinase IIα function at endosomes is regulated by the ubiquitin ligase Itch. | 5.58e-05 | 13 | 30 | 2 | 23146885 | |
| Pubmed | 6.50e-05 | 14 | 30 | 2 | 9373155 | ||
| Pubmed | 7.50e-05 | 15 | 30 | 2 | 23236378 | ||
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 7.50e-05 | 15 | 30 | 2 | 12657787 | |
| Pubmed | 8.57e-05 | 16 | 30 | 2 | 21920314 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 8.85e-05 | 100 | 30 | 3 | 25807483 | |
| Pubmed | 9.70e-05 | 17 | 30 | 2 | 28292929 | ||
| Pubmed | IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. | 9.70e-05 | 17 | 30 | 2 | 19666510 | |
| Pubmed | 1.09e-04 | 18 | 30 | 2 | 23305486 | ||
| Pubmed | 1.22e-04 | 19 | 30 | 2 | 21572392 | ||
| Pubmed | 1.50e-04 | 21 | 30 | 2 | 37005481 | ||
| Pubmed | ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. | 1.50e-04 | 21 | 30 | 2 | 29416926 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 1.64e-04 | 22 | 30 | 2 | 2499654 | |
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 2.13e-04 | 25 | 30 | 2 | 27340223 | |
| Pubmed | 2.13e-04 | 25 | 30 | 2 | 23873930 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 2.31e-04 | 26 | 30 | 2 | 26949039 | |
| Interaction | RNF11 interactions | 3.94e-06 | 169 | 29 | 5 | int:RNF11 | |
| Interaction | SLC24A1 interactions | 1.20e-05 | 4 | 29 | 2 | int:SLC24A1 | |
| Interaction | PRRG3 interactions | 1.99e-05 | 5 | 29 | 2 | int:PRRG3 | |
| Interaction | MARK2 interactions | 4.07e-05 | 274 | 29 | 5 | int:MARK2 | |
| Interaction | CYYR1 interactions | 5.57e-05 | 8 | 29 | 2 | int:CYYR1 | |
| Interaction | MS4A10 interactions | 8.93e-05 | 10 | 29 | 2 | int:MS4A10 | |
| Interaction | PRRG2 interactions | 8.93e-05 | 10 | 29 | 2 | int:PRRG2 | |
| Interaction | ERMN interactions | 8.93e-05 | 10 | 29 | 2 | int:ERMN | |
| Interaction | TMEM252 interactions | 1.09e-04 | 11 | 29 | 2 | int:TMEM252 | |
| Interaction | ILDR1 interactions | 1.09e-04 | 11 | 29 | 2 | int:ILDR1 | |
| Interaction | SCN10A interactions | 1.09e-04 | 11 | 29 | 2 | int:SCN10A | |
| Interaction | CAV3 interactions | 1.43e-04 | 71 | 29 | 3 | int:CAV3 | |
| Interaction | NPC1 interactions | 1.55e-04 | 364 | 29 | 5 | int:NPC1 | |
| Interaction | TMEM171 interactions | 1.75e-04 | 76 | 29 | 3 | int:TMEM171 | |
| Interaction | MOB3A interactions | 1.80e-04 | 14 | 29 | 2 | int:MOB3A | |
| Interaction | LITAF interactions | 1.82e-04 | 77 | 29 | 3 | int:LITAF | |
| Interaction | PRRG1 interactions | 2.08e-04 | 15 | 29 | 2 | int:PRRG1 | |
| Interaction | MAP3K3 interactions | 2.36e-04 | 84 | 29 | 3 | int:MAP3K3 | |
| Interaction | PLEKHM2 interactions | 2.37e-04 | 16 | 29 | 2 | int:PLEKHM2 | |
| Interaction | PRR16 interactions | 2.37e-04 | 16 | 29 | 2 | int:PRR16 | |
| Interaction | SCN3A interactions | 2.37e-04 | 16 | 29 | 2 | int:SCN3A | |
| Interaction | SUSD6 interactions | 2.37e-04 | 16 | 29 | 2 | int:SUSD6 | |
| Interaction | TMEM255A interactions | 2.68e-04 | 17 | 29 | 2 | int:TMEM255A | |
| Interaction | CNGA1 interactions | 2.68e-04 | 17 | 29 | 2 | int:CNGA1 | |
| Interaction | TMEM92 interactions | 2.68e-04 | 17 | 29 | 2 | int:TMEM92 | |
| Interaction | ARRDC3 interactions | 2.84e-04 | 224 | 29 | 4 | int:ARRDC3 | |
| Interaction | TMEM174 interactions | 3.02e-04 | 18 | 29 | 2 | int:TMEM174 | |
| Interaction | RASL11B interactions | 3.37e-04 | 19 | 29 | 2 | int:RASL11B | |
| Interaction | SCN2A interactions | 3.37e-04 | 19 | 29 | 2 | int:SCN2A | |
| Interaction | CLIC2 interactions | 3.74e-04 | 20 | 29 | 2 | int:CLIC2 | |
| Interaction | SCN8A interactions | 3.74e-04 | 20 | 29 | 2 | int:SCN8A | |
| Interaction | KCNQ1 interactions | 4.13e-04 | 21 | 29 | 2 | int:KCNQ1 | |
| Interaction | SCN9A interactions | 4.13e-04 | 21 | 29 | 2 | int:SCN9A | |
| Interaction | ARPC1A interactions | 4.18e-04 | 102 | 29 | 3 | int:ARPC1A | |
| Interaction | SLC22A8 interactions | 4.54e-04 | 22 | 29 | 2 | int:SLC22A8 | |
| Interaction | LONRF3 interactions | 4.54e-04 | 22 | 29 | 2 | int:LONRF3 | |
| Interaction | SCNN1G interactions | 4.54e-04 | 22 | 29 | 2 | int:SCNN1G | |
| Interaction | NDFIP1 interactions | 4.55e-04 | 105 | 29 | 3 | int:NDFIP1 | |
| Interaction | KCNAB1 interactions | 5.88e-04 | 25 | 29 | 2 | int:KCNAB1 | |
| Interaction | DNAH17 interactions | 6.36e-04 | 26 | 29 | 2 | int:DNAH17 | |
| Interaction | OCLN interactions | 6.69e-04 | 500 | 29 | 5 | int:OCLN | |
| Interaction | SLC22A6 interactions | 7.38e-04 | 28 | 29 | 2 | int:SLC22A6 | |
| Interaction | SCNN1B interactions | 7.38e-04 | 28 | 29 | 2 | int:SCNN1B | |
| Interaction | FBXL15 interactions | 7.92e-04 | 29 | 29 | 2 | int:FBXL15 | |
| Interaction | SCN1A interactions | 7.92e-04 | 29 | 29 | 2 | int:SCN1A | |
| Interaction | STAC interactions | 8.48e-04 | 30 | 29 | 2 | int:STAC | |
| Interaction | CDKN2AIPNL interactions | 9.06e-04 | 31 | 29 | 2 | int:CDKN2AIPNL | |
| GeneFamily | Dyneins, axonemal | 1.90e-04 | 17 | 22 | 2 | 536 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 6.43e-04 | 31 | 22 | 2 | 357 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.24e-06 | 193 | 30 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.94e-06 | 197 | 30 | 4 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 148 | 30 | 3 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 148 | 30 | 3 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.41e-04 | 151 | 30 | 3 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.76e-04 | 163 | 30 | 3 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 164 | 30 | 3 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 164 | 30 | 3 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 166 | 30 | 3 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 168 | 30 | 3 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 171 | 30 | 3 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 171 | 30 | 3 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.03e-04 | 171 | 30 | 3 | c2b7bbabc8f9afa8a1157b567d5f962d4b242919 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 173 | 30 | 3 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 173 | 30 | 3 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 173 | 30 | 3 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 173 | 30 | 3 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 173 | 30 | 3 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 173 | 30 | 3 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 174 | 30 | 3 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-04 | 174 | 30 | 3 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-04 | 174 | 30 | 3 | e9e4532a474b4b0938a50ff85c9508aca53cd3ae | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-04 | 175 | 30 | 3 | 78a86cac3e6c0d115c997d1c29ee0e24af54551f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 8e4600efeea095a92178cfd26d7c58db7dfc0c80 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 177 | 30 | 3 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 30 | 3 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-04 | 181 | 30 | 3 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.40e-04 | 181 | 30 | 3 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.44e-04 | 182 | 30 | 3 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.44e-04 | 182 | 30 | 3 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-04 | 184 | 30 | 3 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 185 | 30 | 3 | 4e40d3103ebf4a7066b7ce300b6ef700ba0e2863 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.56e-04 | 185 | 30 | 3 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.56e-04 | 185 | 30 | 3 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 2.56e-04 | 185 | 30 | 3 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-04 | 186 | 30 | 3 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-04 | 186 | 30 | 3 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-04 | 187 | 30 | 3 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.68e-04 | 188 | 30 | 3 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.68e-04 | 188 | 30 | 3 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.68e-04 | 188 | 30 | 3 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 2.68e-04 | 188 | 30 | 3 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.72e-04 | 189 | 30 | 3 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.72e-04 | 189 | 30 | 3 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 189 | 30 | 3 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.72e-04 | 189 | 30 | 3 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.72e-04 | 189 | 30 | 3 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.72e-04 | 189 | 30 | 3 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 189 | 30 | 3 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 190 | 30 | 3 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 190 | 30 | 3 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.77e-04 | 190 | 30 | 3 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-04 | 191 | 30 | 3 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-04 | 191 | 30 | 3 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.81e-04 | 191 | 30 | 3 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-04 | 191 | 30 | 3 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-04 | 191 | 30 | 3 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 191 | 30 | 3 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-04 | 191 | 30 | 3 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 191 | 30 | 3 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 2.81e-04 | 191 | 30 | 3 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 2.81e-04 | 191 | 30 | 3 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-04 | 191 | 30 | 3 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.81e-04 | 191 | 30 | 3 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 191 | 30 | 3 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 191 | 30 | 3 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.81e-04 | 191 | 30 | 3 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 191 | 30 | 3 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 191 | 30 | 3 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 191 | 30 | 3 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 2.81e-04 | 191 | 30 | 3 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 2.81e-04 | 191 | 30 | 3 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-04 | 191 | 30 | 3 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 2.85e-04 | 192 | 30 | 3 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 2.85e-04 | 192 | 30 | 3 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.85e-04 | 192 | 30 | 3 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-04 | 193 | 30 | 3 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.90e-04 | 193 | 30 | 3 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 193 | 30 | 3 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 193 | 30 | 3 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 2.90e-04 | 193 | 30 | 3 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 193 | 30 | 3 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 193 | 30 | 3 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.94e-04 | 194 | 30 | 3 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.94e-04 | 194 | 30 | 3 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.94e-04 | 194 | 30 | 3 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.99e-04 | 195 | 30 | 3 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 195 | 30 | 3 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 195 | 30 | 3 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 195 | 30 | 3 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.99e-04 | 195 | 30 | 3 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.99e-04 | 195 | 30 | 3 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 195 | 30 | 3 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; HL60; HT_HG-U133A | 3.85e-06 | 197 | 28 | 5 | 2908_UP | |
| Disease | Liddle syndrome (implicated_via_orthology) | 5.99e-06 | 4 | 30 | 2 | DOID:0050477 (implicated_via_orthology) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 7.20e-06 | 37 | 30 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 9.02e-05 | 14 | 30 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 3.99e-04 | 29 | 30 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 6.16e-04 | 36 | 30 | 2 | cv:C0008780 | |
| Disease | Combined immunodeficiency | 7.99e-04 | 41 | 30 | 2 | C0494261 | |
| Disease | Microcalcification | 8.39e-04 | 42 | 30 | 2 | C0521174 | |
| Disease | Calcinosis | 8.39e-04 | 42 | 30 | 2 | C0006663 | |
| Disease | Tumoral calcinosis | 8.39e-04 | 42 | 30 | 2 | C0263628 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MFVETLWKVWTELLD | 86 | Q8WY22 | |
| FALVDTKAVWFKKWM | 346 | Q96NH3 | |
| FTTVKLLWIWDKMEK | 101 | Q4W4Y0 | |
| LTIIKKWSWMFQEHL | 1121 | Q96DT5 | |
| EEKTFWKEEKSFWEM | 96 | Q6NSX1 | |
| KKWMAEVDVFLKEEW | 1061 | P11532 | |
| WFRSLFWKEEMELTL | 11 | Q9NVJ2 | |
| WFKALFWKEEMELTL | 11 | Q96BM9 | |
| FKTKTWWLGLFLMLL | 71 | Q6P499 | |
| WFWKAVLMMDSEKRI | 1226 | P46934 | |
| MLILFFLDSLIAWWE | 571 | O60721 | |
| SLMVDWFWLIHEKQL | 776 | Q8IY33 | |
| KKWDFTALIDFWDKV | 566 | Q86W56 | |
| LAEWWELLFFIKKLD | 491 | Q14999 | |
| MEFWLSWVLLVAILK | 1 | A0A0J9YX35 | |
| EKFWEIWLMNEEEAK | 396 | Q96MC2 | |
| KMFWIEATLLWRDIA | 351 | Q01638 | |
| WLEWAIKEYSLMEID | 141 | Q01543 | |
| NTFMEIWKKRWDKFI | 491 | Q9NZK5 | |
| LDLWYLMFKEGWEHK | 241 | Q6ZWL3 | |
| LKTWDMYREIWEINK | 956 | Q9P225 | |
| KWSELIKIVMSWFVS | 151 | Q8WUM9 | |
| MEFWLSWVFLVAISK | 1 | P01767 | |
| AFFWWIALIKMDLSD | 11 | Q9Y2K3 | |
| WQWFDGVMEVLKKHL | 571 | P51692 | |
| MEKRVIKWFDYLWTN | 426 | P29973 | |
| KMDDFWLLKELQTWL | 181 | Q9UBD9 | |
| LIWDLKMDWGLFDKN | 526 | Q9UBH6 | |
| SKRLWKFFWEMDEAE | 636 | P11277 | |
| LKEVWENMPKFDSLW | 96 | Q86XU0 | |
| QWFWKAVLLMDAEKR | 881 | Q96PU5 |